MedTrace Logo

Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"

NCT02786173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-03-13

No results posted yet for this study

Summary

The PRIME Registry is a multi-center, observational study designed to evaluate immediate and long-term outcomes (36 months) of endovascular revascularization in patients with critical limb ischemia (CLI) and advanced peripheral artery disease (PAD).

Conditions

  • Peripheral Arterial Disease
  • Peripheral Vascular Disease
  • Critical Limb Ischemia

Sponsors & Collaborators

  • C. R. Bard

    collaborator INDUSTRY

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Metro Health, Michigan

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2020-12-31
Completion
2021-11-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786173 on ClinicalTrials.gov